Literature DB >> 8383089

Tauroursodeoxycholate and tauro-beta-muricholate exert cytoprotection by reducing intrahepatocyte taurochenodeoxycholate content.

T Ohiwa1, K Katagiri, M Hoshino, T Hayakawa, T Nakai.   

Abstract

Cytoprotection by tauroursodeoxycholic acid and tauro-beta-muricholic acid against taurochenodeoxycholic acid-induced toxicity was examined with reference to intracellular bile acid content in primary cultured rat hepatocytes. In comparison with levels in the group administered taurochenodeoxycholic acid 1 mmol/L alone, lactate dehydrogenase levels in the culture medium decreased significantly in groups simultaneously administered taurochenodeoxycholic acid 1 mmol/L and tauroursodeoxycholic acid 0.5 to 2 mmol/L or tauro-beta-muricholic acid. Results of the trypan blue uptake test indicated that the lactate dehydrogenase release was indeed caused by cell damage. After the administration of tauroursodeoxycholic acid 2 mmol/L or tauro-beta-muricholic acid 2 mmol/L, intracellular taurochenodeoxycholic acid content was consistently reduced to half of that after administration of taurochenodeoxycholic acid alone. Simultaneous administration of dibutyl cyclic AMP also reduced intracellular taurochenodeoxycholic acid content and lactate dehydrogenase release. Being rinsed with tauroursodeoxycholic acid and tauro-beta-muricholic acid after being precultured in taurochenodeoxycholic acid 1 mmol/L also markedly reduced their taurochenodeoxycholic acid content. Taurocholic acid caused limited reduction of intracellular taurochenodeoxycholic acid but not suppression of lactate dehydrogenase release. Taurodehydrocholic acid showed no reduction of taurochenodeoxycholic acid content and no decrease of lactate dehydrogenase release. Although only small amounts of tauroursodeoxycholic acid or tauro-beta-muricholic acid were found to accumulate in hepatocytes, taurocholic acid increased as if replacing taurochenodeoxycholic acid. The results suggest that tauroursodeoxycholic acid or tauro-beta-muricholic acid may exert cytoprotective effects by lowering intracellular taurochenodeoxycholic acid levels associated with their optimal hydrophilicity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383089

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

1.  Response of porcine hepatocytes in primary culture to plasma from severe viral hepatitis patients.

Authors:  Yong-Bo Cheng; Ying-Jie Wang; Shi-Chang Zhang; Jun Liu; Zhi Chen; Jia-Jia Li
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

Review 2.  Ursodeoxycholic acid treatment of vanishing bile duct syndromes.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

3.  Phosphoinositide 3-kinase-dependent Ras activation by tauroursodesoxycholate in rat liver.

Authors:  A K Kurz; C Block; D Graf; S V Dahl; F Schliess; D Häussinger
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

4.  Hepatoprotection with tauroursodeoxycholate and beta muricholate against taurolithocholate induced cholestasis: involvement of signal transduction pathways.

Authors:  P Milkiewicz; M G Roma; E Elias; R Coleman
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

5.  Improvement of cyclosporin A-induced cholestasis by tauroursodeoxycholate in a long-term study in the rat.

Authors:  P E Queneau; P Bertault-Peres; M Guitaoui; E Mesdjian; A Durand; J C Montet
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

6.  Simple steatosis sensitizes cholestatic rats to liver injury and dysregulates bile salt synthesis and transport.

Authors:  Daniël A Lionarons; Michal Heger; Rowan F van Golen; Lindy K Alles; Vincent A van der Mark; Jaap J Kloek; Dirk R de Waart; Hendrik A Marsman; Henny Rusch; Joanne Verheij; Ulrich Beuers; Coen C Paulusma; Thomas M van Gulik
Journal:  Sci Rep       Date:  2016-08-18       Impact factor: 4.379

7.  Dose-response effect of berberine on bile acid profile and gut microbiota in mice.

Authors:  Ying Guo; YouCai Zhang; WeiHua Huang; Felcy Pavithra Selwyn; Curtis D Klaassen
Journal:  BMC Complement Altern Med       Date:  2016-10-18       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.